MORGAN STANLEY PLC/CALL/CVS HEALTH/115/0.1/21.03.25 Stock

Warrant

DE000MG0XGH1

Market Closed - Bid/Ask 03:00:23 2024-05-22 pm EDT Pre-market 02:00:30 am
0.025 EUR -7.41% Intraday chart for MORGAN STANLEY PLC/CALL/CVS HEALTH/115/0.1/21.03.25 0.033 +32.00%
Current month-32.43%
1 month-26.47%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-22 0.025 -7.41%
24-05-21 0.027 -3.57%
24-05-20 0.028 +3.70%
24-05-17 0.027 0.00%
24-05-16 0.027 +3.85%

Delayed Quote Börse Stuttgart

Last update May 22, 2024 at 03:00 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
Issuer Morgan Stanley
WKN MG0XGH
ISINDE000MG0XGH1
Date issued 2024-03-27
Strike 115 $
Maturity 2025-03-21 (303 Days)
Parity 10 : 1
Emission price 0.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.071
Lowest since issue 0.018
Spread 0.015
Spread %37.50%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
57.44 USD
Average target price
71.37 USD
Spread / Average Target
+24.26%
Consensus